company background image
A6X logo

aXichem DB:A6X Stock Report

Last Price

€0.096

Market Cap

€2.8m

7D

-3.6%

1Y

-83.4%

Updated

25 Mar, 2024

Data

Company Financials

A6X Stock Overview

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden.

A6X fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

aXichem AB Competitors

Price History & Performance

Summary of all time highs, changes and price drops for aXichem
Historical stock prices
Current Share Pricekr0.096
52 Week Highkr1.25
52 Week Lowkr0.088
Beta0.13
1 Month Change-14.69%
3 Month Change-60.17%
1 Year Change-83.38%
3 Year Change-97.24%
5 Year Change-98.54%
Change since IPO-97.93%

Recent News & Updates

Recent updates

Shareholder Returns

A6XDE ChemicalsDE Market
7D-3.6%5.6%1.3%
1Y-83.4%8.0%6.4%

Return vs Industry: A6X underperformed the German Chemicals industry which returned 8% over the past year.

Return vs Market: A6X underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is A6X's price volatile compared to industry and market?
A6X volatility
A6X Average Weekly Movement23.8%
Chemicals Industry Average Movement4.5%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: A6X's share price has been volatile over the past 3 months.

Volatility Over Time: A6X's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
19997Torsten Helsinghttps://www.axichem.com

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.

aXichem AB Fundamentals Summary

How do aXichem's earnings and revenue compare to its market cap?
A6X fundamental statistics
Market cap€2.82m
Earnings (TTM)-€1.82m
Revenue (TTM)€158.36k

17.8x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A6X income statement (TTM)
Revenuekr1.81m
Cost of Revenuekr400.00k
Gross Profitkr1.41m
Other Expenseskr22.22m
Earnings-kr20.81m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.97
Gross Margin77.89%
Net Profit Margin-1,150.41%
Debt/Equity Ratio21.2%

How did A6X perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.